津药药业 (600488)
Tianjin Tianyao Pharmaceuticals Co., Ltd.
K-Line Chart
No K-line data available
Company NameJinyao Pharmaceutical Co., Ltd.
Listing Date2001-06-18
Issue Price11.25RMB
Registered Capital109188.66810k RMB
Legal RepresentativeLi Shuxiang
Registered AddressNo. 19, Xinye Ninth Street, West Zone, Tianjin Economic-Technological Development Area
IndustryChemical Pharmaceuticals
Main BusinessResearch, development, production, and sales of corticosteroid and amino acid APIs and preparations
Company ProfileJinyao Pharmaceutical Co., Ltd. (abbreviated as Tianyao Shares) was established on December 1, 1999. It was listed on the Shanghai Stock Exchange on June 18, 2001, with stock code 600488. The predecessor of Tianyao Shares was Tianjin Pharmaceutical Factory, founded in 1939. From the 1950s to 1960s, it took the lead in China in developing, researching, and producing corticosteroid APIs, making it one of the pioneers of corticosteroid drugs in China and an influential research, production, and export base for corticosteroid APIs domestically. In 2017, the company completed the restructuring project of acquiring Tianjin Jinyao Pharmaceutical Co., Ltd. (abbreviated as "Jinyao Pharmaceutical"), achieving a strategic transformation from a single "API" business to a complementary and dual-wheel-driven model of "APIs and preparations." The company currently has 16 holding and associated companies, with total assets of RMB 4.3 billion. Both Tianyao Shares and Jinyao Pharmaceutical are high-tech enterprises. Tianyao Shares primarily produces corticosteroid and amino acid APIs, with over 30 corticosteroid API varieties across six major series, including Dexamethasone, Prednisone, Methylprednisolone, and Betamethasone, in regular production. Its annual production capacity exceeds 250 tons for corticosteroids and 2,000 tons for amino acid APIs.
Stock Details
1. Key Indicators
- Total Shares(W): 109188.67
- Circulating A-Shares(W): 109188.67
- Earnings Per Share(RMB): 0.0640
- Net Assets Per Share(RMB): 2.7686
- Operating Revenue(W RMB): 223153.61
- Total Profit(W RMB): 12816.99
- **Net Profit Attributable to Parent(W RMB) **: 6953.99
- Net Profit Growth Rate(%): -62.75
- Weighted Return on Equity(%): 2.2500
- Operating Cash Flow Per Share(RMB): 0.0310
- Undistributed Profit Per Share(RMB): 1.1433
- Capital Reserve Per Share(RMB): 0.2938
2. Main Business
The main business covers:
- Production and operation of active pharmaceutical ingredients
- Corticosteroid active pharmaceutical ingredients
- Cardiovascular active pharmaceutical ingredients
- Analgesic active pharmaceutical ingredients
3. Company Basic Information
- Company Name: Tianjin Tianyao Pharmaceuticals Co., Ltd.
- Listing Date: 2001-06-18
- Industry: Pharmaceutical Manufacturing
- Address: No. 221 Huanghai Road, Development Zone, Tianjin
- Website: https://www.kingyork.biz/html/2
- Company Profile: Tianjin Tianyao Pharmaceuticals Co., Ltd. was established through asset restructuring by its main sponsor, the former Tianjin Pharmaceutical Co., Ltd. (now renamed Tianjin Pharmaceutical Group Co., Ltd.), jointly with four other sponsors: Tianjin New Technology Industrial Park Science and Technology Development Co., Ltd., Tianjin Central Pharmaceutical Co., Ltd., Tianjin Darentang Pharmaceutical Factory, and Tianjin Pharmaceutical Packaging and Printing Factory.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Tianjin Pharmaceutical Group Co., Ltd. | General Legal Person | 55453.01 | 50.79 |
| 2 | Jinhuhushen Biopharmaceutical Technology Co., Ltd. | General Legal Person | 5820.63 | 5.33 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 1486.87 | 1.36 |
| 4 | Tianjin Yiyao Printing Co., Ltd. | General Legal Person | 381.28 | 0.35 |
| 5 | Jinyuan Shun'an Yuanqi Flexible Allocation Hybrid Securities Investment Fund | Fund | 343.21 | 0.31 |
| 6 | Zhongjia Kexin Hybrid Securities Investment Fund Class A | Fund | 8.30 | 0.01 |
| 7 | Zhongjia Zijin Flexible Allocation Hybrid Securities Investment Fund Class A | Fund | 5.94 | 0.01 |
5. Concept Sectors
- Assisted Reproduction
Remarks
- Data update date: 2025-09-30
- Data source: Public market information